Integra LifeSciences to restart PriMatrix and SurgiMend production at new Braintree facility

Integra LifeSciences announced plans to restart manufacture of PriMatrix and SurgiMend at a new facility in Braintree, Massachusetts, expected to be operational in the first half of 2026, abandoning the Boston facility.

“Integra LifeSciences Holdings Corporation is announcing its plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, Massachusetts.”biopharmawatch.com

• 1 source
• biopharmawatch.comIntegra's New Plans for Braintree Manufacturing Facility - IARTBiopharmaWatch ResearchJul 15, 2024

Summarized from public sources; check the original articles before acting on it.